|
Volumn 5, Issue 1, 1998, Pages 69-72
|
Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: A phase II study
a |
Author keywords
Adriamycin; Alternating regimen; Cyclophosphamide; Etoposide; Ifosfamide; Soft tissue sarcomas; Vincristine
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
VINCRISTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVITY;
FEMALE;
HUMAN;
LUNG METASTASIS;
MALE;
PATIENT COMPLIANCE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT OUTCOME;
TUMOR VOLUME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
ETOPOSIDE;
FEMALE;
HUMANS;
IFOSFAMIDE;
INFUSIONS, INTRAVENOUS;
MALE;
MESNA;
MIDDLE AGED;
NEOPLASM STAGING;
SARCOMA;
SURVIVAL ANALYSIS;
VINCRISTINE;
|
EID: 0031975796
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (2)
|